ISRAEL CORPORATION LIMITED This is an English conven ience translation of the origi na l Hebrew version. In case of any
discrepancy, the binding version is the Hebrew original.
Israel Corpora tion Ltd.
Registrar N u mber: 5200280 I O
Securities of the Corporation are l isted in the Tel Aviv Stock Exchange Short name: Israel Corporation
Address: P.0.B. 20456, Tel Avi v 61204
Tel: 03-6844517, 6844500, Fax:03-6844587 Emai l : MAYAAK@JSRAELCORP. COM
Form 121
Public
To:
To:
Date of Transmission : January 17, 2016
Reference: 2016-01 - 01 1323
The Securities Authority www.isa.gov. i l
The Tel Aviv Stock Exchange
•
wwv.1 tase.co.il
l m mediate Report
The Event: Completion of purchase of the Joint Venture
Attached is an immed iate report of Israel Chemicals Ltd.
The date when the event first became known to the corporation: January 15, 2016 Time: 13:30
The name of the authorized signatory to the report and the name of the authorized electronic signatory : Maya Alcheh-Kaplan
Position: Vice President, General Counsel and Company Secretary Date of signing: January 17, 2016
Where needs take us
January 15, 2016
Completion of 1 5% Investment i n Yunnan Yuntianhua Co.,Ltd.
Further to the Company's announcements of December 16, 2014 and October 12, 2015, regarding the formation of ICL's phosphate joint venture in China (the "YPH JV") with Yunnan Yuntianhua Group, and to Item 4 "Information on t he Company" of the Company's 2014 Annual Report & Note 11 of the Company's 2014 Financial Statements, filed on March 20, 2015, the Company wishes to announce that its wholly-owned subsidiary in China ("ICL China"), has completed an investment in 15% of the issued and outstanding share capital on a fully diluted basis of Yunnan Yuntianhua Co.,Ltd ("YTH"), a Shanghai Stock Exchange listed company, against payment of approximately $250 million in RMB, which represent 8.24 RMB/share as determined on December 16, 2014. The share price at the closing date is 9.10 RMB/Share. ICL's investment in YTH was part of the transaction related to the formation of the YPH JV, which was completed at October 2015. The investment in YTH was completed following its approval by China's Ministry of Commerce and its Securities Regulatory Commission.
As part of the investment in YTH, ICL China w ill nominate two out of 11board members, one of whom will be Stefan Borgas, ICL's President & CEO. ICL's representation on YTH's board,as well as on a phosphate business committee that will be established to oversee YTH's phosphate business, as well as !Cl's right to appoint deputy general managers for YTH and two of its subsidiaries, is expected to permit ICL to have oversight over these businesses and to contribute to their growth and profitability.
Israel Chemicals Ltd.
Name of the authorized signatory on the report and name of authorized electronic reporter: Lisa Haimovitz
Position: Senior VP General Counsel and Company Secretary
Signature Date: January 15, 2016
ICL
Millennium Tower, 23 Aranha St. Tel-Aviv 6107025 Tel. 03-6844400 Fax 03-6844444
www-icl-group.com
J'J
(6107025) J>JN Jn 23 ,'1')1N ,Ol>lJ>!Ji1 7'rlr.l 03·6844444 OiJ:l 03·6844400 )l.!:>7J
ICL – Israel Corporation Limited issued this content on 2016-01-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-25 00:42:26 UTC
Original Document: http://phx.corporate-ir.net/external.file?t=2&item=o8hHt16027g9XhJTr8+weNRYaV9bFc2rMd0Q/AXw4zuc7pIRR5KTW7rkBXaYsxjHfV1xaE/M4Molyid8eXQwgNiyUSGPHlCsKwsHmMJE5Z2LRycbL8AgAkU2T2Icl67Z5Wqo/h2KOcFg2908imgugg==&cb=635892788356766920
